Entry

D01825                      Drug

Name

Fluocinolone acetonide (JP18/USP/INN);
Fluocet (TN);
Retisert (TN);
Synalar (TN)

Product

ILUVIEN (Alimera Sciences), RETISERT (Bausch & Lomb Incorporated), YUTIQ (EyePoint Pharmaceuticals), CAPEX (Galderma Laboratories), FLUOCINOLONE ACETONIDE (Medimetriks Pharmaceuticals), SYNALAR (Medimetriks Pharmaceuticals), SYNALAR (Medimetriks Pharmaceuticals), DERMA-SMOOTHE/FS (Royal Pharmaceuticals), DERMA-SMOOTHE/FS (Royal Pharmaceuticals), DERMOTIC (Royal Pharmaceuticals)

Generic

FLUOCINOLONE ACETONIDE (Amneal Pharmaceuticals LLC), FLUOCINOLONE ACETONIDE (Amneal Pharmaceuticals LLC), FLUOCINOLONE ACETONIDE (Amneal Pharmaceuticals LLC), FLUOCINOLONE ACETONIDE (Bryant Ranch Prepack), FLUOCINOLONE ACETONIDE (Bryant Ranch Prepack), FLUOCINOLONE ACETONIDE (Cosette Pharmaceuticals), FLUOCINOLONE ACETONIDE (Cosette Pharmaceuticals), FLUOCINOLONE ACETONIDE (E. Fougera & Co. a division of Fougera Pharmaceuticals), FLUOCINOLONE ACETONIDE (Glasshouse Pharmaceuticals Limited Canada), FLUOCINOLONE ACETONIDE (Glenmark Pharmaceuticals), FLUOCINOLONE ACETONIDE (Glenmark Pharmaceuticals), FLUOCINOLONE ACETONIDE (Glenmark Pharmaceuticals), FLUOCINOLONE ACETONIDE (Lupin Pharmaceuticals), FLUOCINOLONE ACETONIDE (Marlex Pharmaceuticals), FLUOCINOLONE ACETONIDE (Padagis Israel Pharmaceuticals), FLUOCINOLONE ACETONIDE (Padagis Israel Pharmaceuticals), FLUOCINOLONE ACETONIDE (Padagis Israel Pharmaceuticals), FLAC OTIC OIL (Patrin Pharma), FLUOCINOLONE ACETONIDE (Quagen Pharmaceuticals LLC), FLUOCINOLONE ACETONIDE (Quagen Pharmaceuticals LLC), FLUOCINOLONE ACETONIDE (Quagen Pharmaceuticals LLC), FLUOCINOLONE ACETONIDE (Rising Pharmaceuticals), FLUOCINOLONE ACETONIDE (Rising Pharmaceuticals), FLUOCINOLONE ACETONIDE (Taro Pharmaceuticals U.S.A.), FLUOCINOLONE ACETONIDE (Taro Pharmaceuticals U.S.A.), FLUOCINOLONE ACETONIDE (Taro Pharmaceuticals U.S.A.), FLUOCINOLONE ACETONIDE (Rising Pharmaceuticals), FLUOCINOLONE ACETONIDE OIL, 0.01% (EAR DROPS) (Tasman Pharma), FLUOCINOLONE ACETONIDE TOPICAL (Actavis Pharma), FLUOCINOLONE ACETONIDE TOPICAL SOLUTION USP, 0.01% (Encube Ethicals Private Limited)

Formula

C24H30F2O6

Exact mass

452.201

Mol weight

452.4882

Structure

Simcomp

Class

Anti-inflammatory
DG01955 Corticosteroid
DG02068 Glucocorticoid

Remark

Therapeutic category:

2646

ATC code:

C05AA10 D07AC04 S01BA15 S02BA08

Product:

D01825<JP/US>

Product (mixture):

D04795<JP/US> D11089<US>

Efficacy

Anti-inflammatory, Glucocorticoid receptor agonist

Target

NR3C1 (GR) [HSA:2908] [KO:K05771]

Pathway

hsa04080

Neuroactive ligand-receptor interaction

Interaction

Structure map

map07225

Glucocorticoid and mineralocorticoid receptor agonists/antagonists

Brite

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
  C05 VASOPROTECTIVES
   C05A AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE
    C05AA Corticosteroids
     C05AA10 Fluocinolone acetonide
      D01825  Fluocinolone acetonide (JP18/USP/INN) <JP/US>
D DERMATOLOGICALS
  D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS
   D07A CORTICOSTEROIDS, PLAIN
    D07AC Corticosteroids, potent (group III)
     D07AC04 Fluocinolone acetonide
      D01825  Fluocinolone acetonide (JP18/USP/INN) <JP/US>
S SENSORY ORGANS
  S01 OPHTHALMOLOGICALS
   S01B ANTIINFLAMMATORY AGENTS
    S01BA Corticosteroids, plain
     S01BA15 Fluocinolone acetonide
      D01825  Fluocinolone acetonide (JP18/USP/INN) <JP/US>
  S02 OTOLOGICALS
   S02B CORTICOSTEROIDS
    S02BA Corticosteroids
     S02BA08 Fluocinolone acetonide
      D01825  Fluocinolone acetonide (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
  Dermatitis and Pruitus Agents
   Glucocorticoids, Medium Potency
    Fluocinolone
     D01825  Fluocinolone acetonide (JP18/USP/INN)
   Glucocorticoids, High Potency
    Fluocinolone
     D01825  Fluocinolone acetonide (JP18/USP/INN)
Otic Agents
  Otic Glucocorticoids
   Fluocinolone
    D01825  Fluocinolone acetonide (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2  Agents affecting individual organs
  26  Epidermides
   264  Analgesics, anti-itchings, astringents, anti-inflammatory agents
    2646  Adrenocorticotropic hormones
     D01825  Fluocinolone acetonide (JP18/USP/INN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for integumentary system
  56 Purulent skin remedies
   D01825  Fluocinolone acetonide (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Designated second-class OTC drugs
  Inorganic and organic chemicals
   Fluocinolone acetonide
    D01825  Fluocinolone acetonide (JP18/USP/INN)
Second-class OTC drugs
  Inorganic and organic chemicals
   Fluocinolone acetonide
    D01825  Fluocinolone acetonide (JP18/USP/INN)
Drug groups [BR:br08330]
Anti-inflammatory
  DG01955  Corticosteroid
   DG02068  Glucocorticoid
    D01825  Fluocinolone acetonide
Drug classes [BR:br08332]
Anti-inflammatory
  DG01955  Corticosteroid
   D01825  Fluocinolone acetonide
Target-based classification of drugs [BR:br08310]
Nuclear receptors
  Estrogen like receptors
   3-Ketosteroid receptor
    NR3C1 (GR)
     D01825  Fluocinolone acetonide (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
  D01825  Fluocinolone acetonide
Topical steroids potency [br08317.html]
Classification in the USA
  D01825
Classification in Japan
  D01825

Other DBs

CAS:

67-73-2

PubChem:

7848887

ChEBI:

31623

LigandBox:

D01825

NIKKAJI:

J1.414A

KCF data

ATOM        32
            1   C2x C    18.6900  -29.1900
            2   C5x C    18.6900  -30.5200
            3   C2x C    19.8800  -31.2200
            4   C2y C    21.0700  -30.5200
            5   C1z C    21.0700  -29.1900
            6   C2x C    19.8800  -28.4900
            7   C1y C    22.2600  -31.2200
            8   C1x C    23.4500  -30.5200
            9   C1y C    23.4500  -29.1900
            10  C1z C    22.2600  -28.4900
            11  C1y C    24.5000  -28.4900
            12  C1z C    24.5000  -27.1600
            13  C1x C    23.4500  -26.4600
            14  C1y C    22.2600  -27.1600
            15  C1x C    26.8800  -28.4900
            16  C1y C    26.8800  -27.1600
            17  C1z C    25.6900  -26.4600
            18  O5x O    17.5700  -31.2200
            19  C1a C    21.0700  -27.7900
            20  X   F    22.2600  -29.8200
            21  O1a O    21.0700  -26.4600
            22  C1a C    24.5000  -25.7600
            23  C5a C    25.6900  -24.8500
            24  O2x O    27.0900  -25.5500
            25  O5a O    26.8800  -24.2200
            26  C1b C    24.5000  -24.2200
            27  O1a O    23.4500  -24.8500
            28  O2x O    28.2800  -27.1600
            29  C1z C    28.4900  -25.5500
            30  C1a C    29.8900  -25.5500
            31  C1a C    28.4900  -24.2200
            32  X   F    22.2600  -32.6200
BOND        36
            1     1   2 1
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 1
            6     1   6 2
            7     4   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    5  10 1
            12    9  11 1
            13   11  12 1
            14   12  13 1
            15   13  14 1
            16   10  14 1
            17   11  15 1
            18   15  16 1
            19   16  17 1
            20   12  17 1
            21    2  18 2
            22    5  19 1 #Up
            23   10  20 1 #Down
            24   14  21 1 #Up
            25   12  22 1 #Up
            26   17  23 1 #Up
            27   17  24 1 #Down
            28   23  25 2
            29   23  26 1
            30   26  27 1
            31   16  28 1 #Down
            32   24  29 1
            33   29  28 1
            34   29  30 1
            35   29  31 1
            36    7  32 1 #Down